Literature DB >> 25685292

Glycaemic control, treatment satisfaction and quality of life in type 2 diabetes patients in Greece: The PANORAMA study Greek results.

Iraklis Avramopoulos1, Alexandros Moulis1, Nikos Nikas1.   

Abstract

AIM: To provide an update on glycaemic control in European patients with type 2 diabetes mellitus (T2DM). We present the Greek population data of the study.
METHODS: An observational multicenter, cross-sectional study evaluating glycaemic control and a range of other clinical and biological measures as well as quality of life (QoL) and treatment satisfaction in 375 patients with T2DM enrolled by 25 primary care sites from Greece.
RESULTS: The mean age of the patients was 63.5 years and the male/female ratio 48.9%/51.1%. 79.7% of the patients exerted none or light physical activity, 82.4% were overweight or obese and 32.9% did not meet HbA1c target of less than 7.0% (53 mmol/mol). Patients reported high satisfaction to continue with treatment, high satisfaction with administered treatment and increased willingness to recommend treatment to others (mean Diabetes Treatment Satisfaction Questionnaire score 29.1 ± 5.6). However, 80% of the patients reported that their QoL would be better without diabetes. Finally, the most challenging parameter reported was the lack of freedom to eat and drink.
CONCLUSION: This analysis of the Greek Panorama study results showed that a considerable percentage of T2DM patients in Greece do not achieve glycaemic target levels, despite the favourably reported patient satisfaction from administered therapy. Additionally, the majority of primary care T2DM patients in Greece depict the negative effect of the disease in their QoL.

Entities:  

Keywords:  Quality of life; Treatment satisfaction; Type 2 diabetes mellitus

Year:  2015        PMID: 25685292      PMCID: PMC4317314          DOI: 10.4239/wjd.v6.i1.208

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  32 in total

1.  Clinical outcomes and adherence to medications measured by claims data in patients with diabetes.

Authors:  Manel Pladevall; L Keoki Williams; Lisa Ann Potts; George Divine; Hugo Xi; Jennifer Elston Lafata
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

2.  PANORAMA: a European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus--study design.

Authors:  Clare Bradley; Pedro de Pablos-Velasco; Klaus G Parhofer; Eveline Eschwège; Linda Gönder-Frederick; Dominique Simon
Journal:  Prim Care Diabetes       Date:  2011-07-14       Impact factor: 2.459

3.  Quality of life and satisfaction with treatment in subjects with type 2 diabetes: results in Spain of the PANORAMA study.

Authors:  Pedro Depablos-Velasco; Emilio Salguero-Chaves; Julio Mata-Poyo; Beatriz Derivas-Otero; Ricardo García-Sánchez; Pablo Viguera-Ester
Journal:  Endocrinol Nutr       Date:  2013-09-19

4.  Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes.

Authors:  E Witthaus; J Stewart; C Bradley
Journal:  Diabet Med       Date:  2001-08       Impact factor: 4.359

5.  Depression and risk for onset of type II diabetes. A prospective population-based study.

Authors:  W W Eaton; H Armenian; J Gallo; L Pratt; D E Ford
Journal:  Diabetes Care       Date:  1996-10       Impact factor: 19.112

6.  Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group.

Authors: 
Journal:  Diabetes Care       Date:  1999-07       Impact factor: 19.112

Review 7.  Quality of life and diabetes.

Authors:  R R Rubin; M Peyrot
Journal:  Diabetes Metab Res Rev       Date:  1999 May-Jun       Impact factor: 4.876

8.  Evaluation of risk factors for development of complications in Type II diabetes in Europe.

Authors:  A Liebl; M Mata; E Eschwège
Journal:  Diabetologia       Date:  2002-06-19       Impact factor: 10.122

9.  Global estimates of the prevalence of diabetes for 2010 and 2030.

Authors:  J E Shaw; R A Sicree; P Z Zimmet
Journal:  Diabetes Res Clin Pract       Date:  2009-11-06       Impact factor: 5.602

10.  At last, a weight neutral insulin?

Authors:  A Fritsche; H Häring
Journal:  Int J Obes Relat Metab Disord       Date:  2004-09
View more
  5 in total

1.  Diet-Related Knowledge and Physical Activity in a Large Cohort of Insulin-Treated Type 2 Diabetes Patients: PROGENS ARENA Study.

Authors:  Tomasz Klupa; Michał Możdżan; Janina Kokoszka-Paszkot; Magdalena Kubik; Małgorzata Masierek; Margerita Czerwińska; Maciej T Małecki
Journal:  Int J Endocrinol       Date:  2016-09-14       Impact factor: 3.257

2.  Effectiveness of behavioral change techniques employed in eHealth interventions designed to improve glycemic control in persons with poorly controlled type 2 diabetes: a systematic review and meta-analysis protocol.

Authors:  Mihiretu Kebede; Lara Christianson; Zohaib Khan; Thomas L Heise; Claudia R Pischke
Journal:  Syst Rev       Date:  2017-10-24

3.  Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study.

Authors:  Edward B Jude; Mark Nixon; Caroline O'Leary; Melissa Myland; Nick Gooch; Alka Shaunik; Elisheva Lew
Journal:  Diabetes Ther       Date:  2019-07-18       Impact factor: 2.945

4.  Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real-world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN).

Authors:  Edward B Jude; Caroline O'Leary; Melissa Myland; Mark Nixon; Nick Gooch; Alka Shaunik; Elisheva Lew
Journal:  Endocrinol Diabetes Metab       Date:  2019-09-29

5.  Self-Reported Satisfaction to Treatment, Quality of Life and General Health of Type 2 Diabetes Patients with Inadequate Glycemic Control from North-Eastern Romania.

Authors:  Elena-Daniela Grigorescu; Cristina-Mihaela Lăcătușu; Ioana Crețu; Mariana Floria; Alina Onofriescu; Alexandr Ceasovschih; Bogdan-Mircea Mihai; Laurențiu Șorodoc
Journal:  Int J Environ Res Public Health       Date:  2021-03-21       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.